Organisation paid for research Program year 2020 Source: CMS Open Payments

CNS Clinical Research Group

Neither a doctor nor a teaching hospital

Research payments

$305,256

9 payments

Through program year 2020, CNS Clinical Research Group is reported as receiving $305,256 in research payments, across 9 payments.

By program year

2 rows
Year Kind Amount Payments
2020 Research $24,405 2
2019 Research $280,851 7

Breakdown

Who paid Research payments · program years 2019–2020
  1. Otsuka Pharmaceutical Development & Commercialization, Inc. $174,471 4 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $130,785 5 payments
Studies the money was for Research payments · program years 2019–2020
  1. A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficithyperactivity Disorder Trial 405-201-00013 $139,851 1 payment
  2. A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder $130,785 5 payments
  3. An Open-Label, 52-Week, Multicenter Trial Evaluating the Long-Term Safety and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder $12,980 1 payment
  4. A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder (Trial 405-201-00013) $11,425 1 payment
  5. An Open-Label, 52-Week, Multicenter Trial Evaluating the Long-Term Safety and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficithyperactivity Disorder $10,216 1 payment
What the money was spent on Research payments · program years 2019–2020
  1. Other $130,785 5 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record